tm logo
RX THERAPEUTICS
Live/Registered
REGISTERED

on 13 Aug 2024

Last Applicant/ Owned by

5959 Beaconpark St

Lithia

FL

33547

Serial Number

98038204 filed on 12th Jun 2023

Registration Number

7476773 registered on 13th Aug 2024

in the Supplemental Register

Correspondent Address

Gene Bolmarcich

Gene Bolmarcich

BROOKFIELD, CT 06804

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RX THERAPEUTICS

Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Natural supplements for treating depression and anxiety; Vitamin and mineral supplements

Classification Information


Class [005]
Pharmaceutical Products


Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Natural supplements for treating depression and anxiety; Vitamin and mineral supplements


First Use Date in General

15th Feb 2024

First Use Date in Commerce

15th Feb 2024

Mark Details


Serial Number

No 98038204

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Aug 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Aug 2024REGISTERED-SUPPLEMENTAL REGISTER
05th Jul 2024TEAS/EMAIL CORRESPONDENCE ENTERED
05th Jul 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
05th Jul 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05th Jul 2024USE AMENDMENT ACCEPTED
28th Mar 2024USE AMENDMENT FILED
28th Mar 2024TEAS AMENDMENT OF USE RECEIVED
28th Mar 2024AMENDMENT TO USE PROCESSING COMPLETE
26th Mar 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED